Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
Chronic obstructive pulmonary disease (COPD) remains a major public health problem. It is
the fourth leading cause of chronic morbidity and mortality in the United States, and is …
the fourth leading cause of chronic morbidity and mortality in the United States, and is …
The biodiversity of species and their rates of extinction, distribution, and protection
… (1.1C warming) to 30% (6.4C warming) of the 3349 species studied (72). A global assessment
of expected warming-induced range contractions estimated that 184 to 327 montane bird …
of expected warming-induced range contractions estimated that 184 to 327 montane bird …
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung …
…, AS Buist, PMA Calverley, CR Jenkins… - American journal of …, 2001 - atsjournals.org
… However, this therapy is very expensive, is not available in most countries, and is not
recommended for COPD that is not related to α 1 -antitrypsin deficiency (Evidence C). … In …
recommended for COPD that is not related to α 1 -antitrypsin deficiency (Evidence C). … In …
[HTML][HTML] Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
Background Long-acting beta-agonists and inhaled corticosteroids are used to treat chronic
obstructive pulmonary disease (COPD), but their effect on survival is unknown. Methods We …
obstructive pulmonary disease (COPD), but their effect on survival is unknown. Methods We …
Habitat fragmentation and its lasting impact on Earth's ecosystems
… (A to C) For each fragmentation treatment [reduced area in BDFFP, Wog Wog, Kansas (A);
increased isolation in SRS and Moss (B); and increased edge in all experiments (C)], we …
increased isolation in SRS and Moss (B); and increased edge in all experiments (C)], we …
The effects of antihypertensive therapy on the quality of life
…, B Brown, CJ Bulpitt, CD Jenkins… - … England Journal of …, 1986 - Mass Medical Soc
We conducted a multicenter randomized double-blind clinical trial among 626 men with mild
to moderate hypertension to determine the effects of captopril, methyldopa, and propranolol …
to moderate hypertension to determine the effects of captopril, methyldopa, and propranolol …
Coronary heart disease in the Western Collaborative Group Study: Final follow-up experience of 8 1/2 years
RH Rosenman, RJ Brand, CD Jenkins, M Friedman… - Jama, 1975 - jamanetwork.com
Clinical coronary heart disease (CHD) occurred in 257 subjects during eight to nine years of
follow-up (average, 8 1/2 years) in a prospective study of 39- to 59-year-old employed men. …
follow-up (average, 8 1/2 years) in a prospective study of 39- to 59-year-old employed men. …
Global patterns of terrestrial vertebrate diversity and conservation
CN Jenkins, SL Pimm… - Proceedings of the …, 2013 - National Acad Sciences
Identifying priority areas for biodiversity is essential for directing conservation resources.
Fundamentally, we must know where individual species live, which ones are vulnerable, where …
Fundamentally, we must know where individual species live, which ones are vulnerable, where …
A scale for the estimation of sleep problems in clinical research
CD Jenkins, BA Stanton, SJ Niemcryk… - Journal of clinical …, 1988 - Elsevier
Problems in sleeping are widely prevalent in modern society and are often one of the
presenting complaints of patients consulting physicians. In addition, there is scattered …
presenting complaints of patients consulting physicians. In addition, there is scattered …
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study
…, JA Anderson, GT Ferguson, CR Jenkins… - American journal of …, 2008 - atsjournals.org
Rationale: Chronic obstructive pulmonary disease (COPD) is characterized by an accelerated
decline in lung function. No drug has been shown conclusively to reduce this decline. …
decline in lung function. No drug has been shown conclusively to reduce this decline. …